These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 12137658)

  • 1. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
    Albuquerque LE; Saconato H; Maciel MC
    Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
    Siristatidis CS; Gibreel A; Basios G; Maheshwari A; Bhattacharya S
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD006919. PubMed ID: 26558801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles.
    Daya S
    Cochrane Database Syst Rev; 2000; 2000(2):CD001299. PubMed ID: 10796763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
    Westergaard LW; Bossuyt PM; Van der Veen F; van Wely M
    Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD003973. PubMed ID: 21328264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WITHDRAWN: Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles.
    Daya S; Gunby J
    Cochrane Database Syst Rev; 2007 Jul; 2006(3):CD002810. PubMed ID: 17636708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical outcomes between the depot gonadotrophin-releasing hormone agonist protocol and gonadotrophin-releasing hormone antagonist protocol in normal ovarian responders.
    Xia M; Zheng J
    BMC Pregnancy Childbirth; 2021 May; 21(1):372. PubMed ID: 33975553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles.
    van Wely M; Kwan I; Burt AL; Thomas J; Vail A; Van der Veen F; Al-Inany HG
    Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD005354. PubMed ID: 21328276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro fertilisation and gamete intrafallopian transfer: an integrative analysis of research, 1987-1992.
    Kenny DT
    Br J Obstet Gynaecol; 1995 Apr; 102(4):317-25. PubMed ID: 7612516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials.
    Hsia LH; Lee TH; Lin YH; Huang YY; Chang HJ; Liu YL
    J Assist Reprod Genet; 2023 Sep; 40(9):2063-2077. PubMed ID: 37466846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of human menopausal gonadotropin and follicle-stimulating hormone with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation in in vitro fertilization.
    Yang TS; Wang BC; Chang SP; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):452-6. PubMed ID: 7634183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized study of clomiphene citrate and gonadotrophins versus goserelin and gonadotrophins for follicular stimulation in assisted reproduction.
    Dhont M; Onghena A; Coetsier T; De Sutter P
    Hum Reprod; 1995 Apr; 10(4):791-6. PubMed ID: 7650122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live birth rate following endometrial preparation with daily versus depot GnRH agonist.
    Fidan U; Ozturk M; Ceyhan T; Kazımova L; Karasahin E
    J Obstet Gynaecol; 2023 Dec; 43(2):2274102. PubMed ID: 37902321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis.
    Palomba S; Caserta D; Levi-Setti PE; Busnelli A
    J Ovarian Res; 2024 Mar; 17(1):60. PubMed ID: 38486276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryo quality and uterine receptivity in in-vitro fertilization cycles with or without agonists of gonadotrophin-releasing hormone.
    Testart J; Forman R; Belaisch-Allart J; Volante M; Hazout A; Strubb N; Frydman R
    Hum Reprod; 1989 Feb; 4(2):198-201. PubMed ID: 2521866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian response in repetitive cycles induced by menotrophin alone or combined with gonadotrophin releasing hormone analogue.
    Ron-El R; Raziel A; Herman A; Golan A; Nahum H; Soffer Y; Caspi E
    Hum Reprod; 1990 May; 5(4):427-30. PubMed ID: 2141846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in vitro fertilization.
    Tan SL; Kingsland C; Campbell S; Mills C; Bradfield J; Alexander N; Yovich J; Jacobs HS
    Fertil Steril; 1992 Apr; 57(4):810-4. PubMed ID: 1555692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian stimulation for in-vitro fertilization combining administration of gonadotrophins and blockade of the pituitary with D-Trp6-LHRH microcapsules: pilot studies with two protocols.
    Zorn JR; Barata M; Brami C; Epelboin S; Nathan C; Papageorgiou G; Quantin P; Rolet F; Savale M; Boyer P
    Hum Reprod; 1988 Feb; 3(2):235-9. PubMed ID: 2965712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of gonadotropin releasing hormone agonist (GnRHa) in good responders undergoing repeat in vitro fertilization/embryo transfer (IVF/ET).
    Segars JH; Hill GA; Bryan SH; Herbert CM; Osteen KG; Rogers BJ; Wentz AC
    J In Vitro Fert Embryo Transf; 1990 Dec; 7(6):327-31. PubMed ID: 2127603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized controlled trial of follicle stimulating hormone versus human menopausal gonadotrophin in in-vitro fertilization.
    Daya S; Gunby J; Hughes EG; Collins JA; Sagle MA
    Hum Reprod; 1995 Jun; 10(6):1392-6. PubMed ID: 7593503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WITHDRAWN: Gonadotrophin-releasing hormone analogue as an adjunct to gonadotropin therapy for clomiphene-resistant polycystic ovarian syndrome.
    Hughes E; Collins J; Vandekerckhove P
    Cochrane Database Syst Rev; 1996 Apr; 1996(1):CD000097. PubMed ID: 17636588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.